Cargando…

Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies

PURPOSE: Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is a commonly used drug to reduce total cholesterol and low-density lipoprotein (LDL) levels. Furthermore, several mechanisms showed the wound-healing potential of statins, especially simvastatin. Simvastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi-Simakani, Seyedeh Maryam, Azadi, Amir, Tanideh, Nader, Omidifar, Navid, Ghasemiyeh, Parisa, Mohammadi-Samani, Soliman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676542/
https://www.ncbi.nlm.nih.gov/pubmed/38022815
http://dx.doi.org/10.34172/apb.2023.083
_version_ 1785141304906219520
author Mousavi-Simakani, Seyedeh Maryam
Azadi, Amir
Tanideh, Nader
Omidifar, Navid
Ghasemiyeh, Parisa
Mohammadi-Samani, Soliman
author_facet Mousavi-Simakani, Seyedeh Maryam
Azadi, Amir
Tanideh, Nader
Omidifar, Navid
Ghasemiyeh, Parisa
Mohammadi-Samani, Soliman
author_sort Mousavi-Simakani, Seyedeh Maryam
collection PubMed
description PURPOSE: Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is a commonly used drug to reduce total cholesterol and low-density lipoprotein (LDL) levels. Furthermore, several mechanisms showed the wound-healing potential of statins, especially simvastatin. Simvastatin is a lipophilic drug, therefore, it has low water solubility with limited skin permeability potential. In this regard, nanostructured lipid carriers (NLCs) were recruited as novel topical drug delivery systems to enhance skin adhesion and film formation, maintain skin integrity, sustain the release of simvastatin, and prolong simvastatin skin deposition to help pressure ulcers healing and regeneration. METHODS: NLCs were fabricated using the solvent diffusion evaporation technique. Drug loading, in vitro drug release, and morphological assessment on the optimized formulation were considered. Furthermore, in vivo effect of simvastatin-loaded NLCs gel on pressure ulcer healing was assessed using a rat skin model. Histopathological assessments were compared with conventional simvastatin gel and drug-free NLCs gel. RESULTS: Simvastatin-loaded NLC with an average diameter of 100 nm was considered as the optimum formulation. According to the results entrapment efficiency of simvastatin within the NLCs was about 99.4%. Drug release studies revealed sustained drug release from NLCs in which about 87% of the drug was slowly released during 48 hours. Animal study results confirmed that simvastatin-loaded NLCs gel has better efficacy on pressure ulcers and could significantly reduce inflammation, and promote skin regeneration compared to both drug-free NLCs and conventional simvastatin gels. CONCLUSION: Simvastatin-loaded NLCs with an average particle size of 100 nm would be a promising novel topical drug delivery system with sustained drug release potential for pressure ulcer treatment.
format Online
Article
Text
id pubmed-10676542
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tabriz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-106765422023-05-20 Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies Mousavi-Simakani, Seyedeh Maryam Azadi, Amir Tanideh, Nader Omidifar, Navid Ghasemiyeh, Parisa Mohammadi-Samani, Soliman Adv Pharm Bull Original Article PURPOSE: Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is a commonly used drug to reduce total cholesterol and low-density lipoprotein (LDL) levels. Furthermore, several mechanisms showed the wound-healing potential of statins, especially simvastatin. Simvastatin is a lipophilic drug, therefore, it has low water solubility with limited skin permeability potential. In this regard, nanostructured lipid carriers (NLCs) were recruited as novel topical drug delivery systems to enhance skin adhesion and film formation, maintain skin integrity, sustain the release of simvastatin, and prolong simvastatin skin deposition to help pressure ulcers healing and regeneration. METHODS: NLCs were fabricated using the solvent diffusion evaporation technique. Drug loading, in vitro drug release, and morphological assessment on the optimized formulation were considered. Furthermore, in vivo effect of simvastatin-loaded NLCs gel on pressure ulcer healing was assessed using a rat skin model. Histopathological assessments were compared with conventional simvastatin gel and drug-free NLCs gel. RESULTS: Simvastatin-loaded NLC with an average diameter of 100 nm was considered as the optimum formulation. According to the results entrapment efficiency of simvastatin within the NLCs was about 99.4%. Drug release studies revealed sustained drug release from NLCs in which about 87% of the drug was slowly released during 48 hours. Animal study results confirmed that simvastatin-loaded NLCs gel has better efficacy on pressure ulcers and could significantly reduce inflammation, and promote skin regeneration compared to both drug-free NLCs and conventional simvastatin gels. CONCLUSION: Simvastatin-loaded NLCs with an average particle size of 100 nm would be a promising novel topical drug delivery system with sustained drug release potential for pressure ulcer treatment. Tabriz University of Medical Sciences 2023-11 2023-05-20 /pmc/articles/PMC10676542/ /pubmed/38022815 http://dx.doi.org/10.34172/apb.2023.083 Text en ©2023 The Authors. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers.
spellingShingle Original Article
Mousavi-Simakani, Seyedeh Maryam
Azadi, Amir
Tanideh, Nader
Omidifar, Navid
Ghasemiyeh, Parisa
Mohammadi-Samani, Soliman
Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
title Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
title_full Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
title_fullStr Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
title_full_unstemmed Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
title_short Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
title_sort simvastatin-loaded nanostructured lipid carriers as topical drug delivery system for wound healing purposes: preparation, characterization, and in vivo histopathological studies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676542/
https://www.ncbi.nlm.nih.gov/pubmed/38022815
http://dx.doi.org/10.34172/apb.2023.083
work_keys_str_mv AT mousavisimakaniseyedehmaryam simvastatinloadednanostructuredlipidcarriersastopicaldrugdeliverysystemforwoundhealingpurposespreparationcharacterizationandinvivohistopathologicalstudies
AT azadiamir simvastatinloadednanostructuredlipidcarriersastopicaldrugdeliverysystemforwoundhealingpurposespreparationcharacterizationandinvivohistopathologicalstudies
AT tanidehnader simvastatinloadednanostructuredlipidcarriersastopicaldrugdeliverysystemforwoundhealingpurposespreparationcharacterizationandinvivohistopathologicalstudies
AT omidifarnavid simvastatinloadednanostructuredlipidcarriersastopicaldrugdeliverysystemforwoundhealingpurposespreparationcharacterizationandinvivohistopathologicalstudies
AT ghasemiyehparisa simvastatinloadednanostructuredlipidcarriersastopicaldrugdeliverysystemforwoundhealingpurposespreparationcharacterizationandinvivohistopathologicalstudies
AT mohammadisamanisoliman simvastatinloadednanostructuredlipidcarriersastopicaldrugdeliverysystemforwoundhealingpurposespreparationcharacterizationandinvivohistopathologicalstudies